Induction of apoptosis by high-dose gold nanoparticles in nasopharyngeal carcinoma cells

Auris Nasus Larynx

Volumn 40, Issue 6, 2013, Pages 563-568

  Lan, Ming Ying ^a,b   Hsu, Yen Bin ^a,b   Hsu, Chih Hung ^a,b   Ho, Ching Yin ^a,b   Lin, Jin Ching ^b,c   Lee, Sheng Wei ^d  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL CENTRAL UNIVERSITY   (Taiwan)

Author keywords

Anti tumor; Cancer; Cytotoxicity; Gold nanoparticle; Nasopharyngeal carcinoma

Indexed keywords

GOLD NANOPARTICLE;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; NASOPHARYNX CARCINOMA; NICK END LABELING; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY;

ANTI-TUMOR; CANCER; CYTOTOXICITY; GOLD NANOPARTICLE; NASOPHARYNGEAL CARCINOMA;

APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; GOLD; HUMANS; IN SITU NICK-END LABELING; METAL NANOPARTICLES; MICROSCOPY, ELECTRON; MICROSCOPY, ELECTRON, TRANSMISSION; NASOPHARYNGEAL NEOPLASMS; TRYPAN BLUE;

EID: 84881549328     PISSN: 03858146     EISSN: 18791476     Source Type: Journal    
DOI: 10.1016/j.anl.2013.04.011     Document Type: Article

References (36)

1. Cho W.C. Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol Cancer 2007, 6:1.
2. Frank G., Ondrey S.K.W. Neoplasms of the nasopharynx. Ballenger's otorhinolaryngology head and neck surgery 2003, p.1392-p.1407. BC Decker, Hamilton, Ontario. B.S. James, J.B. John (Eds.).
3. Lan M.Y., Chen C.L., Lin K.T., Lee S.A., Yang W.L., Hsu C.N., et al. From NPC therapeutic target identification to potential treatment strategy. Mol Cancer Ther 2010, 9:2511-2523.
4. Tao Q., Chan A.T. Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Expert Rev Mol Med 2007, 9:1-24.
5. Chou J., Lin Y.C., Kim J., You L., Xu Z., He B., et al. Nasopharyngeal carcinoma-review of the molecular mechanisms of tumorigenesis. Head Neck 2008, 30:946-963.
6. Huang X., Jain P.K., El-Sayed I.H., El-Sayed M.A. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med Sci 2008, 23:217-228.
7. Jain S., Hirst D.G., O'Sullivan J.M. Gold nanoparticles as novel agents for cancer therapy. Br J Radiol 2012, 85:101-113.
8. Glazer E.S., Massey K.L., Zhu C., Curley S.A. Pancreatic carcinoma cells are susceptible to noninvasive radio frequency fields after treatment with targeted gold nanoparticles. Surgery 2010, 148:319-324.
9. Kim D., Jeong Y.Y., Jon S. A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano 2010, 4:3689-3696.
10. Patra C.R., Bhattacharya R., Mukherjee P. Fabrication and functional characterization of goldnanoconjugates for potential application in ovarian cancer. J Mater Chem 2010, 20:547-554.
11. Nitin N., Javier D.J., Richards-Kortum R. Oligonucleotide-coated metallic nanoparticles as a flexible platform for molecular imaging agents. Bioconjug Chem 2007, 18:2090-2096.
12. Sokolov K., Follen M., Aaron J., Pavlova I., Malpica A., Lotan R., et al. Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res 2003, 63:1999-2004.
13. El-Sayed I.H., Huang X., El-Sayed M.A. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer. Nano Lett 2005, 5:829-834.
14. Aydogan B., Li J., Rajh T., Chaudhary A., Chmura S.J., Pelizzari C., et al. AuNP-DG: deoxyglucose-labeled gold nanoparticles as X-ray computed tomography contrast agents for cancer imaging. Mol Imaging Biol 2010, 12:463-467.
15. Chithrani D.B., Jelveh S., Jalali F., van Prooijen M., Allen C., Bristow R.G., et al. Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat Res 2010, 173:719-728.
16. Zhao F., Zhao Y., Liu Y., Chang X., Chen C., Zhao Y. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 2011, 7:1322-1337.
17. Ghosh R., Singh L.C., Shohet J.M., Gunaratne P.H. A gold nanoparticle platform for the delivery of function microRNAs into cancer al cells. Biomaterials 2013, 34:807-816.
18. Kumar A., Zhang X., Liang X.J. Gold nanoparticles: emerging paradigm for targeted drug delivery system. Biotechnol Adv 2012, 10.1016/j.biotechadv.2012.10.002.
19. Ma X., Wu Y., Jin S., Tian Y., Zhang X., Zhao Y., et al. Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment. ACS Nano 2011, 5:8629-8639.
20. Chang M.Y., Shiau A.L., Chen Y.H., Chang C.J., Chen H.H., Wu C.L. Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice. Cancer Sci 2008, 99:1479-1484.
21. Li J.J., Hartono D., Ong C.N., Bay B.H., Yung L.Y. Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials 2010, 31:5996-6003.
22. Li J.J., Lo S.L., Ng C.T., Gurung R.L., Hartono D., Hande M.P., et al. Genomic instability of gold nanoparticle treated human lung fibroblast cells. Biomaterials 2011, 32:5515-5523.
23. Kang B., Mackey M.A., El-Sayed M.A. Nuclear targeting of gold nanoparticles in cancer cells induces DNA damage, causing cytokinesis arrest and apoptosis. J Am Chem Soc 2010, 132:1517-1519.
24. Hainfeld J.F., Slatkin D.N., Smilowitz H.M. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 2004, 49:N309-N315.
25. El-Sayed I.H., Huang X., El-Sayed M.A. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett 2006, 239:129-135.
26. Huang X., Jain P.K., El-Sayed I.H., El-Sayed M.A. Determination of the minimum temperature required for selective photothermal destruction of cancer cells with the use of immunotargeted gold nanoparticles. Photochem Photobiol 2006, 82:412-417.
27. Huang X., Qian W., El-Sayed I.H., El-Sayed M.A. The potential use of the enhanced nonlinear properties of gold nanospheres in photothermal cancer therapy. Lasers Surg Med 2007, 39:747-753.
28. Shenoi M.M., Anderson J., Bischof J.C. Nanoparticle enhanced thermal therapies. Conf Proc IEEE Eng Med Biol Soc 2009, 2009:1979-1982.
29. Pedro R.N., Thekke-Adiyat T., Goel R., Shenoi M., Slaton J., Schmechel S., et al. Use of tumor necrosis factor-alpha-coated gold nanoparticles to enhance radiofrequency ablation in a translational model of renal tumors. Urology 2010, 76:494-498.
30. Jones B.L., Krishnan S., Cho S.H. Estimation of microscopic dose enhancement factor around gold nanoparticles by Monte Carlo calculations. Med Phys 2010, 37:3809-3816.
31. Hainfeld J.F., Dilmanian F.A., Zhong Z., Slatkin D.N., Kalef-Ezra J.A., Smilowitz H.M. Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Phys Med Biol 2010, 55:3045-3059.
32. Chen Y.H., Tsai C.Y., Huang P.Y., Chang M.Y., Cheng P.C., Chou C.H., et al. Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model. Mol Pharm 2007, 4:713-722.
33. Paciotti G.F., Myer L., Weinreich D., Goia D., Pavel N., McLaughlin R.E., et al. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv 2004, 11:169-183.
34. Visaria R.K., Griffin R.J., Williams B.W., Ebbini E.S., Paciotti G.F., Song C.W., et al. Enhancement of tumor thermal therapy using gold nanoparticle-assisted tumor necrosis factor-alpha delivery. Mol Cancer Ther 2006, 5:1014-1020.
35. Dreaden E.C., Mwakwari S.C., Sodji Q.H., Oyelere A.K., El-Sayed M.A. Tamoxifen-poly(ethylene glycol)-thiol gold nanoparticle conjugates: enhanced potency and selective delivery for breast cancer treatment. Bioconjug Chem 2009, 20:2247-2253.
36. Brown S.D., Nativo P., Smith J.A., Stirling D., Edwards P.R., Venugopal B., et al. Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. J Am Chem Soc 2010, 132:4678-4684.